These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 24260576

  • 1. Inhibition of GSK-3β rescues the impairments in bone formation and mechanical properties associated with fracture healing in osteoblast selective connexin 43 deficient mice.
    Loiselle AE, Lloyd SA, Paul EM, Lewis GS, Donahue HJ.
    PLoS One; 2013; 8(11):e81399. PubMed ID: 24260576
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cell autonomous requirement of connexin 43 for osteocyte survival: consequences for endocortical resorption and periosteal bone formation.
    Bivi N, Condon KW, Allen MR, Farlow N, Passeri G, Brun LR, Rhee Y, Bellido T, Plotkin LI.
    J Bone Miner Res; 2012 Feb; 27(2):374-89. PubMed ID: 22028311
    [Abstract] [Full Text] [Related]

  • 4. Exogenous activation of Wnt/β-catenin signaling attenuates binge alcohol-induced deficient bone fracture healing.
    Lauing KL, Sundaramurthy S, Nauer RK, Callaci JJ.
    Alcohol Alcohol; 2014 Feb; 49(4):399-408. PubMed ID: 24627571
    [Abstract] [Full Text] [Related]

  • 5. GSK-3β inhibition suppresses instability-induced osteolysis by a dual action on osteoblast and osteoclast differentiation.
    Amirhosseini M, Madsen RV, Escott KJ, Bostrom MP, Ross FP, Fahlgren A.
    J Cell Physiol; 2018 Mar; 233(3):2398-2408. PubMed ID: 28731198
    [Abstract] [Full Text] [Related]

  • 6. Connexin 43 Modulates Osteogenic Differentiation of Bone Marrow Stromal Cells Through GSK-3beta/Beta-Catenin Signaling Pathways.
    Lin FX, Zheng GZ, Chang B, Chen RC, Zhang QH, Xie P, Xie D, Yu GY, Hu QX, Liu DZ, Du SX, Li XD.
    Cell Physiol Biochem; 2018 Mar; 47(1):161-175. PubMed ID: 29763908
    [Abstract] [Full Text] [Related]

  • 7. Connexin 43 deficiency desensitizes bone to the effects of mechanical unloading through modulation of both arms of bone remodeling.
    Lloyd SA, Loiselle AE, Zhang Y, Donahue HJ.
    Bone; 2013 Nov; 57(1):76-83. PubMed ID: 23891909
    [Abstract] [Full Text] [Related]

  • 8. Anti-DKK1 antibody promotes bone fracture healing through activation of β-catenin signaling.
    Jin H, Wang B, Li J, Xie W, Mao Q, Li S, Dong F, Sun Y, Ke HZ, Babij P, Tong P, Chen D.
    Bone; 2015 Feb; 71():63-75. PubMed ID: 25263522
    [Abstract] [Full Text] [Related]

  • 9. Scl-Ab reverts pro-osteoclastogenic signalling and resorption in estrogen deficient osteocytes.
    Allison H, Holdsworth G, McNamara LM.
    BMC Mol Cell Biol; 2020 Nov 04; 21(1):78. PubMed ID: 33148174
    [Abstract] [Full Text] [Related]

  • 10. Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading.
    Moriishi T, Fukuyama R, Ito M, Miyazaki T, Maeno T, Kawai Y, Komori H, Komori T.
    PLoS One; 2012 Nov 04; 7(6):e40143. PubMed ID: 22768243
    [Abstract] [Full Text] [Related]

  • 11. Upregulation of inflammatory genes and downregulation of sclerostin gene expression are key elements in the early phase of fragility fracture healing.
    Caetano-Lopes J, Lopes A, Rodrigues A, Fernandes D, Perpétuo IP, Monjardino T, Lucas R, Monteiro J, Konttinen YT, Canhão H, Fonseca JE.
    PLoS One; 2011 Feb 11; 6(2):e16947. PubMed ID: 21347301
    [Abstract] [Full Text] [Related]

  • 12. Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing.
    Chen Y, Whetstone HC, Lin AC, Nadesan P, Wei Q, Poon R, Alman BA.
    PLoS Med; 2007 Jul 31; 4(7):e249. PubMed ID: 17676991
    [Abstract] [Full Text] [Related]

  • 13. The G60S connexin 43 mutation activates the osteoblast lineage and results in a resorption-stimulating bone matrix and abrogation of old-age-related bone loss.
    Zappitelli T, Chen F, Moreno L, Zirngibl RA, Grynpas M, Henderson JE, Aubin JE.
    J Bone Miner Res; 2013 Nov 31; 28(11):2400-13. PubMed ID: 23606335
    [Abstract] [Full Text] [Related]

  • 14. Osteocytes Exposed to Titanium Particles Inhibit Osteoblastic Cell Differentiation via Connexin 43.
    Chai H, Huang Q, Jiao Z, Wang S, Sun C, Geng D, Xu W.
    Int J Mol Sci; 2023 Jun 29; 24(13):. PubMed ID: 37446062
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of beta-catenin signaling by Pb leads to incomplete fracture healing.
    Beier EE, Sheu TJ, Buckley T, Yukata K, O'Keefe R, Zuscik MJ, Puzas JE.
    J Orthop Res; 2014 Nov 29; 32(11):1397-405. PubMed ID: 25044211
    [Abstract] [Full Text] [Related]

  • 16. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
    Kamiya N, Shuxian L, Yamaguchi R, Phipps M, Aruwajoye O, Adapala NS, Yuan H, Kim HK, Feng JQ.
    Bone; 2016 Oct 29; 91():53-63. PubMed ID: 27402532
    [Abstract] [Full Text] [Related]

  • 17. Zoledronate promotes bone formation by blocking osteocyte-osteoblast communication during bone defect healing.
    Cui P, Liu H, Sun J, Amizuka N, Sun Q, Li M.
    Histol Histopathol; 2018 Jan 29; 33(1):89-99. PubMed ID: 28345127
    [Abstract] [Full Text] [Related]

  • 18. Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing.
    Bergdolt S, Kovtun A, Hägele Y, Liedert A, Schinke T, Amling M, Huber-Lang M, Ignatius A.
    PLoS One; 2017 Jan 29; 12(6):e0179512. PubMed ID: 28614388
    [Abstract] [Full Text] [Related]

  • 19. Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner.
    Pellegrini GG, Morales CC, Wallace TC, Plotkin LI, Bellido T.
    Nutrients; 2016 Jul 11; 8(7):. PubMed ID: 27409635
    [Abstract] [Full Text] [Related]

  • 20. PKR plays a positive role in osteoblast differentiation by regulating GSK-3β activity through a β-catenin-independent pathway.
    Yoshida K, Okamura H, Ochiai K, Hoshino Y, Haneji T, Yoshioka M, Hinode D, Yoshida H.
    Mol Cell Endocrinol; 2012 Sep 25; 361(1-2):99-105. PubMed ID: 22484461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.